This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
VRNOF Stock Likely to Gain From Its Newly Opened Dispensary in Phoenix
by Zacks Equity Research
Verano is set to open a new Zen Leaf Arcadia in Phoenix, AZ, today. Zen Leaf Arcadia is located at 2710 E Indian School Road, Phoenix. It will be open daily from 8 a.m. to 10 p.m. local time.
Verano Expands U.S. Cannabis Footprint With New Buyouts
by Zacks Equity Research
This deal helps VRNOF foray into the Virginia market ahead of the Adult Use Program launch and will deepen the company's footprint in Arizona cannabis market.
Verano Holdings Corp. (VRNOF) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of 0% and 0.82%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Insulet (PODD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Insulet (PODD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Verano Holdings Corp. (VRNOF) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Verano Holdings Corp. (VRNOF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Verano Holdings Corp. (VRNOF) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of 87.50% and 2.59%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Verano Holdings Corp. (VRNOF) Q1 Earnings Expected to Decline
by Zacks Equity Research
Verano Holdings Corp. (VRNOF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Verano Holdings Corp. (VRNOF) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of -40% and 1.70%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Green Thumb Industries Inc. (GTBIF) Misses Q4 Earnings Estimates
by Zacks Equity Research
Green Thumb Industries Inc. (GTBIF) delivered earnings and revenue surprises of -80% and 3.02%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Medtronic (MDT) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Medtronic (MDT) delivered earnings and revenue surprises of 3.17% and 1.73%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?
Cannabis ETFs: What's Behind the Latest Surge
by Neena Mishra
While marijuana ETFs have seen a recent surge, investors should be aware of the potential risks
Verano Holdings Corp. (VRNOF) Surges 6.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Verano Holdings Corp. (VRNOF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Verano Holdings Corp. (VRNOF) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of 0% and 0.01%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Verano Holdings Corp. (VRNOF) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of -100% and 1.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Haemonetics (HAE) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Haemonetics (HAE) delivered earnings and revenue surprises of 38.16% and 4.50%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Neogen (NEOG) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Neogen (NEOG) delivered earnings and revenue surprises of 40% and 6.38%, respectively, for the quarter ended May 2023. Do the numbers hold clues to what lies ahead for the stock?
Verano Holdings Corp. (VRNOF) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of 57.14% and 0.78%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
BellRing Brands (BRBR) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
BellRing Brands (BRBR) delivered earnings and revenue surprises of 14.29% and 4.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
VAREX IMAGING (VREX) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
VAREX IMAGING (VREX) delivered earnings and revenue surprises of 52.94% and 6.04%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Verano Holdings Corp. (VRNOF) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of 300% and 0.77%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Apyx Medical (APYX) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Apyx (APYX) delivered earnings and revenue surprises of -41.67% and 24.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Verano Holdings Corp. (VRNOF) Q3 Earnings Expected to Decline
by Zacks Equity Research
Verano Holdings Corp. (VRNOF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Verano Holdings Corp. (VRNOF) Soars 31.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Verano Holdings Corp. (VRNOF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Quipt Home Medical Corp. (QIPT) Reports Break-Even Earnings for Q3
by Zacks Equity Research
Quipt Home Medical Corp. (QIPT) delivered earnings and revenue surprises of -100% and 0.65%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
ResMed (RMD) Q4 Earnings Beat Estimates
by Zacks Equity Research
ResMed (RMD) delivered earnings and revenue surprises of 0.68% and 0.29%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?